🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

OptiBiotix Health names David Blain as acting finance director

EditorFrank DeMatteo
Published 23/10/2024, 13:54
OPTIO
-

LONDON - OptiBiotix Health plc, a life sciences company, has announced a key change in its leadership team. Finance Director Graham Myers will step down from the Board on November 30, 2024. David Blain is set to take over as acting Finance Director starting November 1, 2024, with his appointment to the Board pending customary regulatory due diligence.

David Blain is a chartered accountant with the Institute of Chartered Accountants in England and Wales (ICAEW) and brings a wealth of experience to OptiBiotix. He has held financial and board roles in various private and public companies, among them Iksuda Therapeutics Ltd, where he is currently the Financial Director, Applied Graphene Materials plc, Nanoco Group plc, and Inspired Capital plc, previously known as Renovo Group plc.

The transition comes as OptiBiotix prepares for its next growth phase, according to Neil Davidson, the Chairman of OptiBiotix Health plc. Davidson expressed gratitude towards Myers for his contributions over the past year and welcomed Blain to the company.

In addition, the company addressed recent speculation regarding the health of Chief Executive Officer Stephen O'Hara. The company confirmed that O'Hara is on the mend following a brief illness and is expected to return to work soon.

This leadership announcement is based on a press release statement from OptiBiotix Health plc and is intended to provide shareholders and the market with pertinent information regarding these recent developments within the company's executive team.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.